Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study

dc.authorwosidpehlivan, yavuz/AAG-8227-2021
dc.contributor.authorPamuk, Omer Nuri
dc.contributor.authorKisacik, Bunyamin
dc.contributor.authorPamuk, Gulsum Emel
dc.contributor.authorOnat, Ahmet Mesut
dc.contributor.authorSayarlioglu, Mehmet
dc.contributor.authorDonmez, Salim
dc.contributor.authorPehlivan, Yavuz
dc.date.accessioned2024-06-12T11:13:40Z
dc.date.available2024-06-12T11:13:40Z
dc.date.issued2013
dc.departmentTrakya Üniversitesien_US
dc.description.abstractWe evaluated the roles of sociocultural status, distress and cognitive functions in rheumatoid arthritis (RA) patients who developed methotrexate (MTX)-related neutropenia. The data of 37 RA patients with MTX-related neutropenia who were being followed up at 3 centers were evaluated. The control group included 74 RA patients. The clinical features, biochemical tests and treatment modalities of the patients were obtained from hospital files. The mini-mental state examination (MMSE) test and the Hospital Anxiety and Depression Scale (HADS) were administered for all RA patients with neutropenia as well as the control group. The frequencies of male patients, illiterate patients, patients living alone, patients with serious visual impairment, those with low income, and patients with high creatinine were significantly higher among RA patients with MTX-related neutropenia than in controls (p values < 0.05). The RA patients with MTX-related neutropenia had significantly lower MMSE scores, and significantly higher HADS-A and HADS-D scores than controls (p values < 0.05). In addition, the proportion of patients with probable dementia was significantly higher in RA patients with MTX-related neutropenia than in controls (p < 0.001). Twenty-six of the 37 patients (70.3 %) developed neutropenia with daily dosing. Patients who used MTX daily were more likely to be living alone than those using weekly dosing (p = 0.011). Multivariate analysis showed that having probable dementia on the MMSE test (OR 52.6), low income level (OR 56.8) and age (OR 1.12) were independent risk factors for the development of MTX-related neutropenia. The presence of probable dementia on MMSE, low socioeconomical status and older age are associated with serious toxicity in RA patients using MTX. Measures should be taken to prevent wrong MTX dosing by the patients. Compliance and patient education is of major importance, in particular, in the patients presented in this study.en_US
dc.identifier.doi10.1007/s00296-013-2792-2
dc.identifier.endpage2635en_US
dc.identifier.issn0172-8172
dc.identifier.issn1437-160X
dc.identifier.issue10en_US
dc.identifier.pmid23743624en_US
dc.identifier.scopus2-s2.0-84885378395en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage2631en_US
dc.identifier.urihttps://doi.org/10.1007/s00296-013-2792-2
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23641
dc.identifier.volume33en_US
dc.identifier.wosWOS:000324824500024en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofRheumatology Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRheumatoid Arthritisen_US
dc.subjectMethotrexateen_US
dc.subjectNeutropeniaen_US
dc.subjectMini-Mental State Examinationen_US
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectMini-Mental-Stateen_US
dc.subjectLong-Term Safetyen_US
dc.subjectPolymorphismsen_US
dc.titleDo impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative studyen_US
dc.typeArticleen_US

Dosyalar